A hip prosthesis and a spinal fixation system can sit on the same workbench and still land in two completely different regulatory categories once they reach Kemenkes. That’s the part most filings don’t budget for. A manufacturer builds its timeline and pricing around a Class C submission, and everything looks routine, until the technical file reaches the evaluator’s desk and the device comes back reclassified as Class D. The review clock resets, the government fee jumps to a higher tariff, and the evaluator starts asking for clinical evidence nobody planned to prepare.
It happens more often than the regulation itself would suggest, because nowhere in Permenkes No. 62 Tahun 2017 is this reclassification spelled out as a rule. It shows up only in how evaluators actually read a device’s intended use, which is exactly the kind of detail that catches teams off guard mid-filing. If you’re on a regulatory affairs team, running distribution for an orthopaedic brand, or manufacturing implants and eyeing Indonesia as your next market, this is the judgment call worth understanding before you commit to a timeline, not after. What follows walks through how Kemenkes tells a Class C medical device Indonesia apart from a Class D medical device Indonesia, when an implant tips from one into the other, how the Regalkes submission itself unfolds, and what timeline, cost, and market opportunity to plan around before you file.
Why Most Orthopaedic Implants Sit in Class C Medical Device Indonesia Rules
Permenkes No. 62 Tahun 2017 tentang Izin Edar Alat Kesehatan, Alat Kesehatan Diagnostik In Vitro dan Perbekalan Kesehatan Rumah Tangga, issued by the Ministry of Health (Kemenkes), sets out a four-tier risk classification used across every medical device registration in Indonesia: Class A (low risk), Class B (low to moderate risk), Class C (moderate to high risk), and Class D (high risk).
Orthopaedic implants such as plates, screws, intramedullary nails, and single-joint prostheses are invasive, long-term contact devices. Under the classification annex to Permenkes No. 62 Tahun 2017, this profile typically places them in the Class C medical device Indonesia tier for orthopaedic implant registration, the mid-tier category that requires a full technical evaluation but carries a shorter published review target than a Class D medical device Indonesia file.
When an Orthopaedic Implant Moves to Class D Medical Device Indonesia Status
Multiclinical orthopaedic implants, meaning devices cleared for use across several joints, several surgical techniques, or combined with other implant systems, are the group we see reclassified into Class D most often during orthopaedic implant registration. In our experience, this happens because a broader intended-use statement raises the risk profile an evaluator has to assess, even when the physical device and materials are unchanged from a Class C medical device Indonesia equivalent already on file elsewhere.
Pasal 7 of Permenkes No. 62 Tahun 2017 defines Class D as devices that pose a high risk to the patient, but the Ministry’s classification guidance leaves the treatment of borderline, combination, and multi-indication implants to the evaluator’s judgment rather than a fixed formula. That judgment call is exactly where an implant manufacturer’s classification assumption and Kemenkes’s actual determination can diverge.
What Determines Whether an Orthopaedic Implant Is Class C or Class D in Indonesia?
An orthopaedic implant’s class in Indonesia depends on its intended use, invasiveness, and duration of body contact, assessed by Kemenkes against the four-tier system in Permenkes No. 62 Tahun 2017. Single-indication, single-joint implants generally register as Class C. Implants intended for multiple joints, multiple surgical techniques, or use in combination with other implant systems are more often classified as Class D, which adds review time, additional clinical evidence, and a higher PNBP fee.
Kemenkes’s own classification guidance sets out the specific factors an evaluator weighs for every device, not only implants: duration of body contact, the degree and route of invasiveness, whether the device is used in combination with another medical device, its intended purpose, whether its effect is local or systemic, its mechanism of action in the body, and, where relevant, its biological effect. For an orthopaedic implant, the combination and multi-indication factors are usually what push a file from Class C into Class D. Manufacturers should confirm the class through a self-assessment submitted in Regalkes before filing, since an incorrect self-declared class is a common cause of administrative rejection.
Class C vs Class D Orthopaedic Implant Registration at a Glance
The table below summarizes the practical differences a Class C and Class D orthopaedic implant file will run into during medical device registration in Indonesia.
| Criteria | Class C | Class D |
|---|---|---|
| Risk level (Permenkes No. 62/2017) | Moderate to high risk | High risk |
| Typical orthopaedic examples | Plates, screws, intramedullary nails, single-joint prostheses | Multi-indication joint systems, multiclinical spinal implants, combination implant systems |
| Review target, domestic device | 30 working days | 40 working days |
| Review target, imported device | 40 working days | 55 working days |
| Clinical evidence standard | Literature-based clinical evaluation usually accepted | Full evaluation under Permenkes No. 63/2017, often local data |
| PNBP government fee | Lower tariff tier | Higher tariff tier (PP No. 64/2019) |
Review-day targets reflect the service standard published under Permenkes No. 62 Tahun 2017 and are counted from the fixed receipt (tanda terima tetap) date, not from initial upload. They exclude time spent responding to technical queries. Service standards and fee structures are periodically updated through instruments such as Permenkes No. 11 Tahun 2025, so confirm the current SLA before setting a client-facing timeline.
Legal Basis for Orthopaedic Implant Registration in Indonesia
The following instruments govern orthopaedic implant registration and are the primary references an SME reviewer should check against before publication:
- Undang-Undang No. 17 Tahun 2023 tentang Kesehatan (Pemerintah Republik Indonesia): Pasal 143 requires anyone producing or distributing a medical device to hold the relevant izin edar from the central or regional government, the umbrella legal basis for the izin edar requirement described throughout this article.
- Permenkes No. 62 Tahun 2017 (Kementerian Kesehatan): Izin Edar Alat Kesehatan, Alat Kesehatan Diagnostik In Vitro dan Perbekalan Kesehatan Rumah Tangga; the foundational classification and licensing regulation.
- Permenkes No. 63 Tahun 2017 (Kementerian Kesehatan): Cara Uji Klinik Alat Kesehatan yang Baik; governs the clinical evidence and good clinical practice standard applied to implants.
- Permenkes No. 11 Tahun 2025 (Kementerian Kesehatan), effective 3 October 2025: Standar Kegiatan Usaha dan Standar Produk/Jasa pada Penyelenggaraan Perizinan Berusaha Berbasis Risiko Subsektor Kesehatan; the current risk-based licensing standard covering Izin Edar procedures processed through Regalkes.
- PP No. 64 Tahun 2019 (Pemerintah Republik Indonesia): Jenis dan Tarif atas Penerimaan Negara Bukan Pajak yang Berlaku pada Kementerian Kesehatan; sets the PNBP fee structure referenced by device class.
- ASEAN Medical Device Directive (AMDD), Annex 4: the ASEAN Common Submission Dossier Template (CSDT), the dossier format Indonesia requires for Regalkes submissions.
The Regalkes Submission Process for Orthopaedic Implant Registration
The Regalkes submission process is the digital backbone of every medical device registration in Indonesia, and orthopaedic implants move through it in five stages.
1. Local Entity, IDAK, and CDAKB
Foreign orthopaedic manufacturers cannot hold their own Izin Edar. A locally established distributor holding a valid IDAK (Izin Distributor Alat Kesehatan) and CDAKB (Cara Distribusi Alat Kesehatan yang Baik) certificate must act as the license holder. Because implants sit in Class C or D, Kemenkes verifies the local entity’s CDAKB status before the technical file is opened for review.
2. ASEAN CSDT Medical Device Indonesia Dossier Preparation
The dossier follows the ASEAN Common Submission Dossier Template, or ASEAN CSDT medical device Indonesia format, under Annex 4 of the AMDD: administrative data, device description and classification, technical documentation, quality management system evidence such as an ISO 13485 certificate, performance and safety data, and labeling and IFU. In our experience, the technical documentation section needs the most rework for an implant file, since global dossiers rarely include the Bahasa Indonesia labeling and local risk-management addendum Kemenkes expects.
3. Submission and PNBP Payment
The completed CSDT dossier is uploaded through the Regalkes submission process at regalkes.kemkes.go.id. Once the self-declared class is verified, the applicant pays the PNBP fee within the payment window the system sets, after which the fixed receipt is issued and the technical evaluation clock starts.
4. Technical Evaluation and Queries
For orthopaedic implants specifically, evaluators commonly raise queries on biocompatibility test scope, sterilization validation, and, for Class D files, the depth of clinical evidence submitted under Permenkes No. 63 Tahun 2017. Each query response resets part of the review clock, so response speed matters as much as the initial dossier quality.
5. NIE Issuance and Validity
Once the evaluation is complete, Kemenkes issues the Nomor Izin Edar (NIE). The license is valid for five years from issuance, after which the license holder must renew before expiry to keep the implant on the market.
Orthopaedic Implant Clinical Data Indonesia Requirements
Orthopaedic implant clinical data Indonesia expectations differ by class. Class C orthopaedic implants can often rely on a literature-based clinical evaluation report supported by bench and biocompatibility testing, provided the device is substantially equivalent to implants with an established safety record. Class D implants, especially multiclinical systems, are evaluated against the good clinical practice standard in Permenkes No. 63 Tahun 2017, and evaluators more often ask for clinical data reflecting actual use in Indonesian patients rather than data drawn only from other markets.
In our experience, manufacturers who prepare an Indonesia-specific clinical evaluation report addendum before submission, rather than waiting for a query to ask for it, cut one to two review cycles off a Class D orthopaedic implant registration timeline.
Cost of Medical Device Registration in Indonesia for Orthopaedic Implants
The cost of medical device registration in Indonesia starts with a government fee for Izin Edar, a Penerimaan Negara Bukan Pajak (PNBP) payment set out in PP No. 64 Tahun 2019, and it scales with device class, with a Class D medical device Indonesia tariff running higher than a Class C medical device Indonesia tariff. The PNBP payment is only one line item on an orthopaedic implant registration budget.
In our experience, the larger cost of medical device registration in Indonesia drivers for an orthopaedic implant file are local testing where SNI or KAN-accredited laboratory testing applies, Bahasa Indonesia translation of technical documentation, the local IDAK/CDAKB-holding representative’s service fee, and, for Class D multiclinical devices, the incremental cost of preparing local clinical data. Because these components vary by device configuration, we recommend requesting a line-item estimate for your specific implant rather than budgeting from a generic industry figure.
How Implant-Specific Adjustments Affect Timeline and Cost
Being an implant changes the file even when the base classification stays the same. In our experience, reviewers consistently ask for adjustments a non-implant Class C device would not need: sterilization shelf-life data tied to the exact packaging configuration, material traceability documentation for the metal or polymer used, and an Indonesia-specific risk management addendum under ISO 14971 addressing long-term implantation risk.
Each of these adjustments, combined with the Class C to Class D reclassification risk discussed earlier, is why two orthopaedic implants filed under the same nominal class can still end up on very different real-world timelines.
Market Potential for Orthopaedic Implants in Indonesia
Getting the classification and dossier right matters commercially, not just administratively. Indonesia’s orthopaedic devices market was valued at approximately US$206.9 million in 2024 and is projected to grow at a compound annual rate of around 6.6% through 2029, reaching roughly US$284.5 million, driven by rising healthcare spending, an expanding middle class, and greater access to orthopaedic surgery outside major cities.
For manufacturers and distributors, that growth is a narrow window, not a permanent one: every month lost to a misjudged classification, an incomplete dossier, or an avoidable query is a month a competitor’s device spends on formulary lists and in operating rooms instead of yours. This is where the commercial and regulatory sides of orthopaedic implant registration meet, since a realistic, well-sequenced filing is what actually determines how soon a device can start generating revenue in the Indonesian market.
Product Registration Indonesia supports this from the commercial side as well as the regulatory side: our pre-submission classification review is designed to catch a likely Class D reclassification before it derails a launch date, and our line-item cost estimates let a manufacturer’s finance and business development teams model the Indonesian opportunity with real numbers rather than industry averages. Getting the file right the first time is, in practice, a market-entry-speed decision as much as a compliance one.
How Product Registration Indonesia Can Help With Your Orthopaedic Implant Registration
Our Medical Device Registration service covers ASEAN CSDT dossier preparation, Regalkes submission, and technical query management for Class A through Class D devices, including orthopaedic implants. For manufacturers without an established Indonesian entity, our License Holder Service lets us act as your local IDAK/CDAKB-holding representative and Izin Edar license holder.
If your implant is likely to fall into the Class D multiclinical category discussed above, our team can run a pre-submission classification review before you commit to a filing timeline, following the same dossier discipline outlined in our ASEAN CSDT cheat sheet for medical device registration.
Get Expert Help With Your Orthopaedic Implant Registration
You don’t have to guess at your device’s classification or budget from a generic industry figure. Our Medical Device Registration team works with manufacturers and distributors every day to confirm a device’s class, map out the dossier requirements, and set a realistic timeline before a single document is filed with Regalkes.
Ready to move forward? Fill out the form below to talk to team, and one of our regulatory specialists will get back to you with next steps for your orthopaedic implant registration.
